Business Context and Reporting Period
This Form 8-K is a current report filed by Inpixon (trading symbol: INPX) on September 18, 2023. The registrant is incorporated in Nevada and its common stock is listed on The Nasdaq Capital Market. The filing addresses corporate governance amendments and the rescheduling of a Special Meeting of Stockholders.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and meeting logistics.
Material Changes
- By-Laws Amendments: The Board approved two amendments effective September 18, 2023:
- Amendment No. 3: Grants the Board full power and authority to amend the By-Laws as permitted by Nevada Revised Statutes (NRS).
- Amendment No. 4: Revises provisions regarding the removal of directors and filling of vacancies to align with NRS 78.335. Additionally, it reduces the quorum requirement for stockholder meetings from a majority of outstanding shares to one-third of outstanding shares.
- Special Meeting Reschedule: The Special Meeting of Stockholders, originally scheduled for August 3, 2023, and previously postponed to September 8, 2023, and October 2, 2023, has been rescheduled to Friday, September 29, 2023, at 10:00 a.m. Pacific Time.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management outlook, or discussion of business risks. The primary operational update is the change in the quorum threshold, which may impact the ability to conduct business at future stockholder meetings with lower attendance. The Special Meeting will remain a completely virtual event, and the record date remains June 21, 2023.
Key Facts for Investor Verification
- Verify the new quorum requirement of one-third of outstanding shares for stockholder meetings.
- Confirm the new date for the Special Meeting of Stockholders: September 29, 2023.
- Note that the record date for the Special Meeting remains June 21, 2023.
- Review the full text of By-Laws Amendment No. 3 and No. 4 (filed as Exhibits 3.1 and 3.2) for complete legal details.